Skip to main content
Virax Biolabs Group Limited (VRAX)
NASDAQ: VRAX · Real-Time Price · USD
0.200
-0.015 (-6.76%)
At close: Mar 9, 2026, 4:00 PM EDT
0.210
+0.010 (5.00%)
After-hours: Mar 9, 2026, 7:53 PM EDT

Virax Biolabs Group Revenue

Virax Biolabs Group had revenue of $1.61K in the half year ending September 30, 2025, a decrease of -97.90%. This brings the company's revenue in the last twelve months to $2.99K, down -96.48% year-over-year. In the fiscal year ending March 31, 2025, Virax Biolabs Group had annual revenue of $6.33K, down -95.95%.

Revenue (ttm)
$2.99K
Revenue Growth
-96.48%
P/S Ratio
497.22
Revenue / Employee
$157
Employees
19
Market Cap
1.48M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 20256.33K-150.09K-95.95%
Mar 31, 2024156.42K147.86K1,727.11%
Mar 31, 20238.56K--
Mar 31, 2022---
Mar 31, 2021123.82K23.94K23.97%
Mar 31, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

VRAX News

More News